Passage BIO, Inc. (PASG) — Institutional Holders, Q2 2026

29 institutional investment managers reported a PASG position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $6.8M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

PASG in Q2 2026: what funds did

Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.

New positions

4

Added to

5

Trimmed

7

Sold out

9

Biggest buyers

  1. BALYASNY ASSET MANAGEMENT L.P.New · +107,025 sh+$522.3K
  2. Lynx1 Capital ManagementAdded · +50,055 sh+$244.3K
  3. Ikarian CapitalAdded · +31,393 sh+$153.2K
  4. DELTEC ASSET MANAGEMENTNew · +15,000 sh+$73.2K
  5. HRT FINANCIALNew · +12,712 sh+$62.0K

Biggest sellers

  1. Vestal Point CapitalSold out · -305,000 sh-$1.5M
  2. Eversept PartnersSold out · -131,581 sh-$642.1K
  3. RENAISSANCE TECHNOLOGIESTrimmed · -85,720 sh-$418.3K
  4. Erste Asset Management GmbHTrimmed · -44,597 sh-$217.6K
  5. DIADEMA PARTNERSSold out · -19,530 sh-$95.3K

PASG 13F holders ranked 1–29 of 29

Institutional investors reporting a position in Passage BIO, Inc. on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
Lynx1 Capital Management#1 · 673,759 sh$3.3M+8.0%
VANGUARD CAPITAL MANAGEMENT#2 · 113,964 sh$556.1K0.0%
BALYASNY ASSET MANAGEMENT L.P.#3 · 107,025 sh$522.3KNew
Ikarian Capital#4 · 99,517 sh$485.6K+46.1%
Yiheng Capital Management, L.P.#5 · 86,097 sh$420.2K0.0%
RENAISSANCE TECHNOLOGIES#6 · 47,892 sh$233.7K-64.2%
Erste Asset Management GmbH#7 · 40,665 sh$197.2K-52.3%
GEODE CAPITAL MANAGEMENT#8 · 37,026 sh$180.7K-10.5%
Verdad Advisers#9 · 30,728 sh$150.0K+38.9%
BOOTHBAY FUND MANAGEMENT#10 · 28,439 sh$138.8K+50.7%
BlackRock#11 · 27,910 sh$136.2K-2.4%
ACADIAN ASSET MANAGEMENT#12 · 22,496 sh$109.0K-7.0%
VANGUARD FIDUCIARY#13 · 17,049 sh$83.2K0.0%
DELTEC ASSET MANAGEMENT#14 · 15,000 sh$73.2KNew
UBS Group AG#15 · 13,565 sh$66.2K-50.7%
HRT FINANCIAL#16 · 12,712 sh$62.0KNew
FIDUCIARY#17 · 10,750 sh$52.5K0.0%
GTS SECURITIES#18 · 10,000 sh$48.8KNew
MORGAN STANLEY#19 · 2,389 sh$11.7K-9.8%
Vanguard Global Advisers#20 · 638 sh$3.1K0.0%
BARCLAYS PLC#21 · 212 sh$1.0K0.0%
SBI Securities , Ltd.#22 · 169 sh$825.00+36.3%
WELLS FARGO & COMPANY#23 · 115 sh$561.000.0%
OSAIC#24 · 15 sh$73.000.0%
JPMORGAN CHASE#25 · 15 sh$73.000.0%
BNP PARIBAS FINANCIAL MARKETS#26 · 12 sh$59.000.0%
LRI Investments#27 · 12 sh$59.000.0%
HARBOUR INVESTMENTS#28 · 3 sh$15.000.0%
TSFG#29 · 5 sh$0.000.0%

Funds that sold out of PASG in Q2 2026 (9)

Held PASG at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.

Institutions that held PASG in Q1 2026 and reported no position in Q2 2026.
InstitutionValue in Q1 2026
Vestal Point Capital305,000 sh$2.4M
Eversept Partners131,581 sh$1.0M
DIADEMA PARTNERS19,530 sh$153.3K
XTX Topco Ltd12,627 sh$99.1K
Persistent Asset Partners Ltd4,955 sh$38.9K
Rockefeller Capital Management L.P.800 sh$6.3K
Tower Research Capital (TRC)502 sh$3.9K
Parallel Advisors16 sh$126.00
ROYAL BANK OF CANADA2 sh$0.00

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.